Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 20, 2013

View Archived Issues

Antiviral activity seen in clinical trial of polio virus candidate pocapavir

New rat model of pulmonary hypertension devised

Nampt inhibitors jointly disclosed by FORMA Therapeutics and Genentech

Daiichi Sankyo and Mitsubishi UFJ Capital establish new open innovation business

Novel Mer kinase inhibitors synthesized at the University of North Carolina

Preclinical and clinical results for antibacterial GSK-2140944 presented

Valneva forms cell line agreement with Delta-Vir

Milestone achieved in arGEN-X's collaboration with Shire

AEterna Zentaris disorazol Z conjugates target LHRH receptor-positive tumors

Mundipharma commences European study of Flutiform in COPD

Diagnoplex and Unilabs to market the Colox colon cancer test

New molecular imaging agents studied for fluorescence-guided brain cancer surgery

Viralytics' phase II Cavatak trial achieves primary endpoint

Prima BioMed reports topline data from phase II CVac trial

FDA accepts Triferic as trade name for investigational iron-delivery drug SFP

BARDA exercises additional funding to develop Aeolus's drug for acute radiation syndrome

Takeda obtains first approval for Oblean in Japan

Chugai gains Japanese approval for HER2-targeted antibody-drug conjugate

First approval for dual bronchodilator Ultibro inhalation capsules by Japanese MHLW

Kyorin gains approval in Japan for combination asthma treatment

GlaxoSmithKline receives orphan drug designations in Japan for multiple drugs

Amgen synthesizes serine/threonine-protein kinase pim inhibitors

CDK7 inhibitors reported in Lead Discovery Center patent

Benitec Biopharma divulges ddRNAi agents for pain

Relvar Ellipta receives approval in Japan, recommendation in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...